All Articles

A landmark deal for 'Talking Tom Heroes' shows how integrated streaming, gaming, and toys are becoming the new standard for children's entertainment.

Free yoga and lunchtime concerts in downtown DC are more than just a pleasant distraction. They're a strategic investment in the city's future, a new form of soft infrastructure designed to rewire a post-pandemic urban core.

Beyond the pink ribbons, the CIBC Run for the Cure is a funding powerhouse. We unpack the 30-year alliance that's fueling AI-driven diagnostics and policy battles.

A landmark report reveals arthritis isn't just a health issue; it's a massive economic drain poised to grow, costing Canada nearly 5% of its GDP annually.

ElevateBio's new COO, Steven Falcone, is a strategic weapon against the crushing cost of advanced therapy manufacturing. This isn't just a hire; it's a war on the price of miracles.

A top general joins a defense AI firm, promising to revolutionize military readiness. But does the well-trod path from battlefield to boardroom accelerate innovation or just grease the wheels of the military-industrial complex?

With its acquisition of TEAM Companies, DISA is betting on specialized tech to manage the risks of an expanding contractor workforce in high-stakes industries.

Adicet Bio nears a pivotal data readout for its lupus CAR-T, now viable for outpatient use, while launching a novel solid tumor attack in prostate cancer.

Private equity firm Great Hill Partners backs insurtech MGA Aurenity, betting that AI-driven underwriting is the key to mastering the complex E&S market.

With Hepatitis C royalties declining, Enanta Pharmaceuticals faces investors this month to sell its vision: a future built on novel RSV and immunology drugs.

As Iron Mountain executives prepare for key tech conferences, they aren't just presenting financials; they're selling a new identity as a data infrastructure leader.

In an age of deepfakes, a leading AI firm is launching a podcast on... ancient history. Sumsub's 'Trust Forward' bets our future depends on the past.

An estimated 13 million Americans live with Dupuytren's contracture, a progressive hand condition. A new campaign using mixed reality aims to change that.

Regis Corp reports mixed FY26 results, but a deeper dive reveals a strategic turnaround. With operational gains and a key debt battle, is the salon giant set for growth?

A new public-private alliance aims to fast-track critical diagnostics and medical devices, bridging the gap between innovation and emergency preparedness.

As enterprises grapple with AI risks, a new platform puts them back in control. Airrived's Sovereign AI promises security, predictability, and autonomy.

With a $700M partnership, Medtronic isn't just buying another robot. It's building a flexible surgical ecosystem to challenge market dominance globally.

As Weltrade marks two decades, its new risk-free World Cup tests trader skill, proprietary tech, and the power of algorithms in a synthetic arena.

A new report reveals a productivity crisis fueled by financial stress. For leaders, ignoring employee financial health is no longer a viable option.

As AI agents begin to manage our finances, EMVCo has unveiled a new framework to ensure they act on our behalf. Can 'Intent Services' build trust?